Clinical trial NCT04337125: Contribution of Attachment and Educational Practices in the Expression of ADHD in School-aged Children
Official title: Cross-sectional Study Assessing the Contribution of Attachment and Educational Practices in the Expression of ADHD in School-aged ADHD Children and Control Group
Study type: INTERVENTIONAL
Overall status: UNKNOWN
Phase: NA
Conditions: Attention Deficit Hyperactivity Disorder
Keywords: child
attachment
parenting
ADHD
executive functions
Lead sponsor: Queen Fabiola Children's University Hospital
Sponsor class: OTHER
Collaborators: name: The Belgian Kids' Fund
First posted: 2020-04-07
Enrollment: 160
Sex: ALL
Minimum age (years): 7
Maximum age (years): 10
Standard ages: CHILD
Accepts healthy volunteers: yes
Allocation: NON_RANDOMIZED
Intervention model: PARALLEL
Primary purpose: OTHER

Brief summary: ADHD is a neurodevelopmental disorder characterized by the presence of persistent signs of associated hyperactivity-impulsivity and/or inattention that impair the child's functioning or development.

The involvement of genetic factors has been shown in numerous studies. Other studies have also highlighted the contributions of parent-child interaction in the development, expression and persistence of symptoms.However, the mechanisms by which parenting practices and attachment may influence ADHD symptoms remain unclear.

The aim of this study is to evaluate the influence of attachment style of the child, the educational practices and the presence of attentional/executive disorders of parents on the expression of ADHD in children aged 7 to 10.

This prospective empirical research will compare children with ADHD and their parents to a matched control group.


Eligibility criteria: Inclusion Criteria:

Male or female patients ages 7 to ≤10 years with ADHD (study group) or TD children matched by gender and socio-economic factors (control group) and their parents.

French-speaking population Willing and able to comply with scheduled visits and study procedures. Written informed consent/assent, according to local guidelines, signed by the patient and / or by the parents or legal guardian prior to any study related screening procedures are performed.

Exclusion Criteria:

Children with intellectual disabilities (IQ \<80). Epilepsy. Prematurity. Objectified neurological sequelae. Specific language impairment or severe learning disabilities. Contraindication to stopping treatment for ADHD

Primary outcomes:
measure: Cartes pour l'évaluation de l'Attachement et de la Mentalisation chez l'Enfant (CAME)
timeFrame: At enrollment
measure: Security Scale - version français (SS-vf)
timeFrame: At enrollment
Secondary outcomes:
measure: Parent Education Practices Assessment Questionnaire (PEP)
timeFrame: At enrollment
measure: Parent Educational Practices perceived by the child (PEPPE)
timeFrame: At enrollment
measure: Behavioral Rating Inventory Executive Function (BRIEF)
timeFrame: At enrollment
measure: Behavioral Rating Inventory Executive Function for Adult (BRIEF-A)
timeFrame: At enrollment
measure: Test of Attentional Performance (TAP)
timeFrame: At enrollment
measure: Stroop
timeFrame: At enrollment
measure: Counting Stroop Task
timeFrame: At enrollment
measure: Tower of London
timeFrame: At enrollment
measure: Attention Deficit Hyperactivity Disorder-Rating Scale (ADHD-RS)
timeFrame: At enrollment
measure: Emotional Regulation Checklist - version française (ERC-vf)
timeFrame: At enrollment
measure: Children Behavior Checklist (CBCL)
timeFrame: At enrollment
measure: Revised Card Sorting Test (RCST)
timeFrame: At enrollment
measure: Kiddie-SADS-PL
timeFrame: At enrollment
measure: Wechsler Intelligence Scale for Children 5th edition (WISC-V)
timeFrame: At enrollment
measure: Wechsler Adult Intelligence Scale 4th edition (WAIS-IV)
timeFrame: At enrollment
measure: Mini International Neuropsychiatric Interview (MINI)
timeFrame: At enrollment
measure: ADHD Adult Scale Rating Scale (ASRS)
timeFrame: At enrollment
measure: Wenders Utah Rating Scale (WURS)
timeFrame: At enrollment
measure: Relationship Scale Questionnaire (RSQ)
timeFrame: At enrollment
measure: Beck Depression Inventory-II (BDI-II)
timeFrame: At enrollment
measure: Children's Sleep Habit Questionnaire (CSHQ)
timeFrame: At enrollment
Other outcomes:
Locations:
city: Brussels
country: Belgium
facility: Hôpital Universitaire Des Enfants Reine Fabiola
city: Brussels
country: Belgium
facility: Hôpital Erasme
Study officials:
affiliation: Queen Fabiola Children's University Hospital
name: Véronique Delvenne, MDPhD
role: STUDY_DIRECTOR
References: